Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Drugs of Abuse Testing Devices Market by Type (Saliva Testing, Breath Testing, Urine Testing, Blood Testing, Hair & Sweat Testing, Otehr), By Application (Hospitals, Diagnostics Laboratories, On-The-Spot Testing, Forensic Laboratories, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Drugs of Abuse Testing Devices Market by Type (Saliva Testing, Breath Testing, Urine Testing, Blood Testing, Hair & Sweat Testing, Otehr), By Application (Hospitals, Diagnostics Laboratories, On-The-Spot Testing, Forensic Laboratories, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 326054 4200 Medical Devices & Consumables 377 136 Pages 4.6 (34)
                                          

Market Overview:


The global drugs of abuse testing devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of drug abuse, growing demand for on-the-spot drug testing, and rising awareness about the benefits of early diagnosis and treatment. Based on type, the global drugs of abuse testing devices market is segmented into saliva testing, breath testing, urine testing, bloodtesting, hair & sweattesting,, and other types. The urine Testing segment is expected to account for the largest share in terms of revenue in 2018 owing to its high adoption rates across hospitals and diagnostic laboratories worldwide.


Global Drugs of Abuse Testing Devices Industry Outlook


Product Definition:


Drugs of abuse testing devices are used to detect the presence of drugs in a person's system. They are important because they can help to ensure that people are not using drugs while they are working or driving.


Saliva Testing:


Saliva testing is a process of analyzing oral fluid for the presence of drugs or toxins. This test is usually conducted on arrestees, patients in hospitals, and people suspected to be under the influence of drugs. The tests are also conducted on victims of drug-related crimes and witnesses to determine if they have been using any illegal substance. Saliva tests are also used as an aid in alcohol abuse detection along with smoking cessation programs.


Breath Testing:


Breath testing is a procedure wherein an individual's breath is analyzed for the presence of drugs of abuse. The test also helps in detecting other compounds such as alcohol, nicotine, and caffeine. This technique has been used by law enforcement agencies to detect drug-impaired drivers which have contributed to its growing demand among road safety organizations.


Application Insights:


On the basis of application, the global drugs of abuse testing devices market is segmented into hospitals, diagnostics laboratories, on-the-spot testing facilities, forensic laboratories and others. Hospitals held the largest share in 2017 owing to factors such as high prevalence of drug abuse and rising number of detoxification centers. Moreover, government initiatives such as Methadone Treatment Centers Assistance Program (MTCAP) are expected to drive growth over the forecast period. On-the-spot testing facilities are anticipated to witness fastest growth during the forecast period due to increasing awareness about availability of quick tests for illicit drugs among consumers and healthcare professionals. For instance, according to a survey conducted by DATCP UK in 2018 regarding demand for heroin on-the- spot tests in England; around 99% people supported mandatory provisioning under law with Naloxone kits at point of sale across Europe.


Regional Analysis:


North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of new technologies and increasing demand for drugs-of-abuse testing devices from law enforcement agencies. The region is expected to maintain its dominance throughout the forecast period owing to factors such as favorable government initiatives pertaining towards drug abuse testing, growing awareness about these tests and availability of advanced products.


Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising prevalence of substance abuse disorders coupled with improving healthcare infrastructure in this region. In addition, economic development in countries such as India & China has led them being among top five tobacco producers globally; thereby boosting product demand for nicotine replacement therapy programs which are further fueling growth in Asia Pacific market for drugs-of-abuse testing devices in the future years.


Growth Factors:


  • Increasing demand for drugs of abuse testing devices due to increasing incidences of drug abuse across the globe.
  • Growing awareness about the harmful effects of drug abuse and its impact on society and individuals is driving the demand for drugs of abuse testing devices.
  • Technological advancements in drugs of abuse testing devices are helping to improve their accuracy, sensitivity, and speed which is further propelling the growth of this market.
  • The increasing number of government initiatives towards curbing drug addiction is also fueling the demand for drugs of abuse testing devices worldwide.

Scope Of The Report

Report Attributes

Report Details

Report Title

Drugs of Abuse Testing Devices Market Research Report

By Type

Saliva Testing, Breath Testing, Urine Testing, Blood Testing, Hair & Sweat Testing, Otehr

By Application

Hospitals, Diagnostics Laboratories, On-The-Spot Testing, Forensic Laboratories, Other

By Companies

F. Hoffmann La-Roche, Siemens Healthineers, Thermo Fisher Scientific, Abbott, Shimadzu, Laboratory Corporation of America Holdings, Dragerwerk, Express Diagnostics International, F. Hoffmann La-Roche

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

136

Number of Tables & Figures

96

Customization Available

Yes, the report can be customized as per your need.


Global Drugs of Abuse Testing Devices Market Report Segments:

The global Drugs of Abuse Testing Devices market is segmented on the basis of:

Types

Saliva Testing, Breath Testing, Urine Testing, Blood Testing, Hair & Sweat Testing, Otehr

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals, Diagnostics Laboratories, On-The-Spot Testing, Forensic Laboratories, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. F. Hoffmann La-Roche
  2. Siemens Healthineers
  3. Thermo Fisher Scientific
  4. Abbott
  5. Shimadzu
  6. Laboratory Corporation of America Holdings
  7. Dragerwerk
  8. Express Diagnostics International
  9. F. Hoffmann La-Roche

Global Drugs of Abuse Testing Devices Market Overview


Highlights of The Drugs of Abuse Testing Devices Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Saliva Testing
    2. Breath Testing
    3. Urine Testing
    4. Blood Testing
    5. Hair & Sweat Testing
    6. Otehr
  1. By Application:

    1. Hospitals
    2. Diagnostics Laboratories
    3. On-The-Spot Testing
    4. Forensic Laboratories
    5. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Drugs of Abuse Testing Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Drugs of Abuse Testing Devices Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Drugs of abuse testing devices are used to screen for the presence of drugs in a person's body. These devices can be used to test for substances such as cocaine, marijuana, and methamphetamine.

Some of the key players operating in the drugs of abuse testing devices market are F. Hoffmann La-Roche, Siemens Healthineers, Thermo Fisher Scientific, Abbott, Shimadzu, Laboratory Corporation of America Holdings, Dragerwerk, Express Diagnostics International, F. Hoffmann La-Roche.

The drugs of abuse testing devices market is expected to grow at a compound annual growth rate of 7.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drugs of Abuse Testing Devices Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Drugs of Abuse Testing Devices Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Drugs of Abuse Testing Devices Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Drugs of Abuse Testing Devices Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Drugs of Abuse Testing Devices Market Size & Forecast, 2020-2028       4.5.1 Drugs of Abuse Testing Devices Market Size and Y-o-Y Growth       4.5.2 Drugs of Abuse Testing Devices Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Saliva Testing
      5.2.2 Breath Testing
      5.2.3 Urine Testing
      5.2.4 Blood Testing
      5.2.5 Hair & Sweat Testing
      5.2.6 Otehr
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Hospitals
      6.2.2 Diagnostics Laboratories
      6.2.3 On-The-Spot Testing
      6.2.4 Forensic Laboratories
      6.2.5 Other
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Drugs of Abuse Testing Devices Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Drugs of Abuse Testing Devices Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Saliva Testing
      9.6.2 Breath Testing
      9.6.3 Urine Testing
      9.6.4 Blood Testing
      9.6.5 Hair & Sweat Testing
      9.6.6 Otehr
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Hospitals
      9.10.2 Diagnostics Laboratories
      9.10.3 On-The-Spot Testing
      9.10.4 Forensic Laboratories
      9.10.5 Other
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Saliva Testing
      10.6.2 Breath Testing
      10.6.3 Urine Testing
      10.6.4 Blood Testing
      10.6.5 Hair & Sweat Testing
      10.6.6 Otehr
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Hospitals
      10.10.2 Diagnostics Laboratories
      10.10.3 On-The-Spot Testing
      10.10.4 Forensic Laboratories
      10.10.5 Other
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Saliva Testing
      11.6.2 Breath Testing
      11.6.3 Urine Testing
      11.6.4 Blood Testing
      11.6.5 Hair & Sweat Testing
      11.6.6 Otehr
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Hospitals
      11.10.2 Diagnostics Laboratories
      11.10.3 On-The-Spot Testing
      11.10.4 Forensic Laboratories
      11.10.5 Other
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Saliva Testing
      12.6.2 Breath Testing
      12.6.3 Urine Testing
      12.6.4 Blood Testing
      12.6.5 Hair & Sweat Testing
      12.6.6 Otehr
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Hospitals
      12.10.2 Diagnostics Laboratories
      12.10.3 On-The-Spot Testing
      12.10.4 Forensic Laboratories
      12.10.5 Other
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Saliva Testing
      13.6.2 Breath Testing
      13.6.3 Urine Testing
      13.6.4 Blood Testing
      13.6.5 Hair & Sweat Testing
      13.6.6 Otehr
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Hospitals
      13.10.2 Diagnostics Laboratories
      13.10.3 On-The-Spot Testing
      13.10.4 Forensic Laboratories
      13.10.5 Other
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Drugs of Abuse Testing Devices Market: Competitive Dashboard
   14.2 Global Drugs of Abuse Testing Devices Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 F. Hoffmann La-Roche
      14.3.2 Siemens Healthineers
      14.3.3 Thermo Fisher Scientific
      14.3.4 Abbott
      14.3.5 Shimadzu
      14.3.6 Laboratory Corporation of America Holdings
      14.3.7 Dragerwerk
      14.3.8 Express Diagnostics International
      14.3.9 F. Hoffmann La-Roche

Our Trusted Clients

Contact Us